0 works0 citations0 h-index

Mary L. Disis

University of Washington(US)Seattle University(US)

Publications by Year

Research Areas

Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immune Cell Function and Interaction

Most-Cited Works

→ Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival(2004)5,022 cited
→ Clinical significance of tumor-infiltrating lymphocytes in breast cancer(2016)843 cited
→ Gene expression markers of Tumor Infiltrating Leukocytes(2017)836 cited
→ Tumor antigen-specific T helper cells in cancer immunity and immunotherapy(2005)675 cited
→ Toxicities of Immunotherapy for the Practitioner(2015)645 cited
→ Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes(2016)627 cited

→ Immune Regulation of Cancer(2010)

482 cited

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.(1994)

→ Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients(2001)450 cited

→ Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based Vaccines(2002)425 cited